» Articles » PMID: 28441421

High Prevalence of MRSA and ESBL Among Asylum Seekers in the Netherlands

Overview
Journal PLoS One
Date 2017 Apr 26
PMID 28441421
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Migration is one of the risk factors for the spread of multidrug-resistant organisms (MDRO). The increasing influx of migrants challenges local health care systems. To provide evidence for both hospital hygiene measure and empirical antibiotic therapy, we analysed all cultures performed in asylum seekers between January 1st 2014 and December 31st 2015 for methicillin resistant Staphylococcus aureus (MRSA) and for multidrug-resistant Enterobacteriaceae (MDRE). We compared these with cultures from the Dutch patient population with risk factors for carriage of MDRO. A total of 7181 patients were screened for MRSA. 7357 S. aureus were isolated in clinical cultures. Of 898 screened asylum seekers, almost 10% were MRSA positive. Of 118 asylum seekers with S. aureus in clinical cultures almost 19% were MRSA positive. The general patient population had a 1.3% rate of MRSA in S. aureus isolates. A higher rate of Panton-Valentine leukocidin (PVL) positive strains (RR: 2.4; 95% CI: 1.6-3.4) was found in asylum seekers compared to the general patient population. In 33475 patients one or more Enterobacteriaceae were obtained. More than 21% of the asylum seekers were carrier of MDRE, most of them producing extended spectrum beta-lactamases (20.3%). 5.1% of the general patient population was MDRE carrier. It can be concluded that asylum seekers present with higher rate of MDRO compared to the general patient population. These results justify continued screening of asylum seekers to anticipate multidrug-resistant organisms during hospital care of patients.

Citing Articles

Antimicrobial Resistance and Migration: Interrelation Between Two Hot Topics in Global Health.

Cotugno S, De Vita E, Frallonardo L, Novara R, Papagni R, Asaduzzaman M Ann Glob Health. 2025; 91(1):12.

PMID: 40061583 PMC: 11887466. DOI: 10.5334/aogh.4628.


Impact of wars and natural disasters on emerging and re-emerging infectious diseases.

Topluoglu S, Taylan-Ozkan A, Alp E Front Public Health. 2023; 11:1215929.

PMID: 37727613 PMC: 10505936. DOI: 10.3389/fpubh.2023.1215929.


Community-acquired antimicrobial resistance among Syrian refugees and the local population in Türkiye.

Yildiz S, Hekimoglu C, Sucakli M, Bakkaloglu Z, Numanoglu Cevik Y, Unaldi O Eur J Public Health. 2023; 33(5):809-814.

PMID: 37464952 PMC: 10567246. DOI: 10.1093/eurpub/ckad119.


Travel-related respiratory symptoms and infections in travellers (2000-22): a systematic review and meta-analysis.

Lovey T, Hasler R, Gautret P, Schlagenhauf P J Travel Med. 2023; 30(5).

PMID: 37310895 PMC: 10481419. DOI: 10.1093/jtm/taad081.


Success rates of MRSA decolonization and factors associated with failure.

Yiek W, Tromp M, Strik-Albers R, van Aerde K, van der Geest-Blankert N, Wertheim H Antimicrob Resist Infect Control. 2022; 11(1):143.

PMID: 36414999 PMC: 9682637. DOI: 10.1186/s13756-022-01177-w.


References
1.
Teicher C, Ronat J, Fakhri R, Basel M, Labar A, Herard P . Antimicrobial drug-resistant bacteria isolated from Syrian war-injured patients, August 2011-March 2013. Emerg Infect Dis. 2014; 20(11):1949-51. PMC: 4214314. DOI: 10.3201/eid2011.140835. View

2.
Heudorf U, Krackhardt B, Karathana M, Kleinkauf N, Zinn C . Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015. Euro Surveill. 2016; 21(2). DOI: 10.2807/1560-7917.ES.2016.21.2.30109. View

3.
Balkhair A, Al-Farsi Y, Al-Muharrmi Z, Al-Rashdi R, Al-Jabri M, Neilson F . Epidemiology of multi-drug resistant organisms in a teaching hospital in oman: a one-year hospital-based study. ScientificWorldJournal. 2014; 2014:157102. PMC: 3914445. DOI: 10.1155/2014/157102. View

4.
Jain A, Agarwal A, Verma R . Cefoxitin disc diffusion test for detection of meticillin-resistant staphylococci. J Med Microbiol. 2008; 57(Pt 8):957-961. DOI: 10.1099/jmm.0.47152-0. View

5.
Szmigielski S, Prevost G, Monteil H, Colin D, Jeljaszewicz J . Leukocidal toxins of staphylococci. Zentralbl Bakteriol. 1999; 289(2):185-201. DOI: 10.1016/s0934-8840(99)80105-4. View